Mycovia Pharmaceuticals Inc.
Mycovia Pharmaceuticals is dedicated to making a difference in patients' lives by advancing treatments for under-addressed medical conditions, with a focus on women's health and overlooked diseases. They develop innovative therapies through science, collaborate with partners, and are committed to treatment equality and community impact.
Industries
Nr. of Employees
small (1-50)
Mycovia Pharmaceuticals Inc.
Patents
Products
Oral oteseconazole capsules (150 mg)
Oral small-molecule antifungal therapy formulated as 150 mg capsules indicated for treatment of severe vulvovaginal candidiasis (as described on product pages and prescribing information).
Oral oteseconazole capsules (150 mg)
Oral small-molecule antifungal therapy formulated as 150 mg capsules indicated for treatment of severe vulvovaginal candidiasis (as described on product pages and prescribing information).
Services
Program to accept and review independent investigator study concepts, supply request forms, and offer limited, non-design-influencing support.
Telephone and email-based medical information service and designated channel for adverse event and product complaint reporting.
Negotiation and management of licensing agreements and commercialization collaborations with regional partners.
Program to accept and review independent investigator study concepts, supply request forms, and offer limited, non-design-influencing support.
Telephone and email-based medical information service and designated channel for adverse event and product complaint reporting.
Negotiation and management of licensing agreements and commercialization collaborations with regional partners.
Expertise Areas
- Antifungal drug development
- Clinical trial design and management
- Clinical pharmacology and safety assessment
- Pharmacovigilance and medical information
Key Technologies
- Small-molecule antifungal drug development
- Clinical trial management and registry reporting
- Clinical pharmacology assessments (PK/PD; renal/hepatic impairment; QT interval)
- Pharmacovigilance and adverse event reporting systems